According to Telix Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$0.23. In 2022 the company made an earnings per share (EPS) of -$0.23 a decrease over its 2021 EPS that were of -$0.21.
Year | EPS | Change |
---|---|---|
2022 | -$0.23 | 10.63% |
2021 | -$0.21 | 53.99% |
2020 | -$0.13 | 60.51% |
2019 | -$0.08360 | 73.49% |
2018 | -$0.04819 | 24.02% |
2017 | -$0.03885 | |
2000 | -$0.008424 | 72% |
1999 | -$0.004898 |